RS64915B1 - Novi derivati triterpena kao inhibitori hiv-a - Google Patents
Novi derivati triterpena kao inhibitori hiv-aInfo
- Publication number
- RS64915B1 RS64915B1 RS20231163A RSP20231163A RS64915B1 RS 64915 B1 RS64915 B1 RS 64915B1 RS 20231163 A RS20231163 A RS 20231163A RS P20231163 A RSP20231163 A RS P20231163A RS 64915 B1 RS64915 B1 RS 64915B1
- Authority
- RS
- Serbia
- Prior art keywords
- hiv inhibitors
- triterpene derivatives
- novel triterpene
- novel
- derivatives
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 150000003648 triterpenes Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201941005217 | 2019-02-11 | ||
| PCT/IB2020/051048 WO2020165741A1 (en) | 2019-02-11 | 2020-02-11 | Novel triterpene derivatives as hiv inhibitors |
| EP20720927.1A EP3924361B1 (en) | 2019-02-11 | 2020-02-11 | Novel triterpene derivatives as hiv inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS64915B1 true RS64915B1 (sr) | 2023-12-29 |
Family
ID=70416451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20231163A RS64915B1 (sr) | 2019-02-11 | 2020-02-11 | Novi derivati triterpena kao inhibitori hiv-a |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20220177439A1 (sr) |
| EP (2) | EP3924361B1 (sr) |
| JP (1) | JP2022520384A (sr) |
| KR (1) | KR20210127955A (sr) |
| CN (1) | CN113727989B (sr) |
| AU (1) | AU2020222299C1 (sr) |
| BR (1) | BR112021015762A2 (sr) |
| CA (1) | CA3129743A1 (sr) |
| DK (1) | DK3924361T3 (sr) |
| EA (1) | EA202192111A1 (sr) |
| ES (1) | ES2965305T3 (sr) |
| FI (1) | FI3924361T3 (sr) |
| HR (1) | HRP20231582T1 (sr) |
| HU (1) | HUE064262T2 (sr) |
| IL (1) | IL285487A (sr) |
| LT (1) | LT3924361T (sr) |
| MX (1) | MX2021009584A (sr) |
| PL (1) | PL3924361T3 (sr) |
| PT (1) | PT3924361T (sr) |
| RS (1) | RS64915B1 (sr) |
| SI (1) | SI3924361T1 (sr) |
| WO (1) | WO2020165741A1 (sr) |
| ZA (1) | ZA202106037B (sr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4103579A4 (en) * | 2020-02-11 | 2024-05-01 | Hetero Labs Limited | NOVEL TRITEPENDENT DERIVATIVES AS HIV INHIBITORS |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58152815A (ja) | 1982-03-05 | 1983-09-10 | Tamio Nishimura | 医療用抗ウイルス剤 |
| AU699168B2 (en) | 1993-07-09 | 1998-11-26 | University Of Pittsburgh | Selection and use of antiviral peptides |
| WO1998046238A1 (en) | 1997-04-15 | 1998-10-22 | Medichem Research, Inc. | Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent |
| HUP9701080A3 (en) | 1997-06-23 | 1999-05-28 | Gene Res Lab Inc New York N | Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative |
| US6427248B1 (en) | 1997-10-09 | 2002-08-06 | David M. Albert | Grip-enhancing glove |
| AU7268000A (en) | 1999-07-21 | 2001-02-13 | Martin Heinkelein | Method for quantization of the antiviral effect of antiviral active principles |
| WO2003037908A1 (en) | 2001-10-31 | 2003-05-08 | Ribapharm Inc. | Antiviral combination therapy and compositions |
| WO2004089357A2 (en) | 2003-04-02 | 2004-10-21 | Regents Of The University Of Minnesota | Anti-fungal formulation of triterpene and essential oil |
| TW200628161A (en) | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| WO2008127364A2 (en) | 2006-10-13 | 2008-10-23 | Myriad Genetics, Inc. | Antiviral compounds and use thereof |
| WO2008057420A2 (en) * | 2006-11-03 | 2008-05-15 | Panacos Pharmaceuticals, Inc. | Extended triterpene derivatives |
| GB2462235B8 (en) | 2007-05-11 | 2013-03-27 | Biotechnology Res Corp Ltd | Receptor modulators exhibiting neuroprotective andmemory enhancing activities |
| CN101367861A (zh) | 2007-08-15 | 2009-02-18 | 中国药科大学 | 2-羟基-3-脱氧五环三萜类化合物及其衍生物、其制备方法及用途 |
| WO2009100532A1 (en) | 2008-02-14 | 2009-08-20 | Virochem Pharma Inc. | NOVEL 17ß LUPANE DERIVATIVES |
| CN102164942B (zh) | 2008-09-19 | 2017-02-15 | 生物科技研究有限公司 | 三萜系化合物及其使用的方法 |
| US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| CN102399254A (zh) | 2010-09-07 | 2012-04-04 | 中国药科大学 | 新型五环三萜衍生物、其制备方法及用途 |
| EA022470B1 (ru) | 2011-01-31 | 2016-01-29 | Бристол-Маерс Сквибб Компани | C-17 и c-3 модифицированные тритерпеноиды с ингибиторной активностью созревания вич |
| WO2013020245A1 (en) | 2011-08-08 | 2013-02-14 | Glaxosmithkline Llc | Carbonyl derivatives of betulin |
| KR20130028442A (ko) | 2011-09-09 | 2013-03-19 | 학교법인 한동대학교 | 항노화 활성을 갖는 베툴린산과 그 유도체 및 이를 함유하는 조성물 |
| KR20140069167A (ko) * | 2011-09-21 | 2014-06-09 | 브리스톨-마이어스 스큅 컴퍼니 | 항바이러스 활성을 갖는 신규 베툴린산 유도체 |
| US8906889B2 (en) | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
| WO2013160810A2 (en) | 2012-04-24 | 2013-10-31 | Hetero Research Foundation | Novel betulinic acid derivatives as hiv inhibitors |
| US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
| WO2014105926A1 (en) | 2012-12-31 | 2014-07-03 | Hetero Research Foundation | Novel betulinic acid proline derivatives as hiv inhibitors |
| CA2900124A1 (en) | 2013-02-06 | 2014-08-14 | Bristol-Myers Squibb Company | C-19 modified triterpenoids with hiv maturation inhibitory activity |
| JP6186012B2 (ja) | 2013-02-25 | 2017-08-23 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｃ−３アルキルおよびアルケニル修飾ベツリン酸誘導体 |
| WO2017017630A1 (en) * | 2015-07-28 | 2017-02-02 | Hetero Research Foundation | Novel betulinic substituted amide derivatives as hiv inhibitors |
| WO2017149518A1 (en) * | 2016-03-04 | 2017-09-08 | Hetero Labs Limited | C-3 novel triterpene with c-17 amine derivatives as hiv inhibitors |
| EP4103579A4 (en) * | 2020-02-11 | 2024-05-01 | Hetero Labs Limited | NOVEL TRITEPENDENT DERIVATIVES AS HIV INHIBITORS |
-
2020
- 2020-02-11 WO PCT/IB2020/051048 patent/WO2020165741A1/en active Application Filing
- 2020-02-11 CA CA3129743A patent/CA3129743A1/en active Pending
- 2020-02-11 EP EP20720927.1A patent/EP3924361B1/en active Active
- 2020-02-11 LT LTEPPCT/IB2020/051048T patent/LT3924361T/lt unknown
- 2020-02-11 SI SI202030333T patent/SI3924361T1/sl unknown
- 2020-02-11 MX MX2021009584A patent/MX2021009584A/es unknown
- 2020-02-11 RS RS20231163A patent/RS64915B1/sr unknown
- 2020-02-11 FI FIEP20720927.1T patent/FI3924361T3/fi active
- 2020-02-11 ES ES20720927T patent/ES2965305T3/es active Active
- 2020-02-11 PT PT207209271T patent/PT3924361T/pt unknown
- 2020-02-11 JP JP2021546849A patent/JP2022520384A/ja active Pending
- 2020-02-11 CN CN202080027246.1A patent/CN113727989B/zh active Active
- 2020-02-11 HR HRP20231582TT patent/HRP20231582T1/hr unknown
- 2020-02-11 KR KR1020217028594A patent/KR20210127955A/ko unknown
- 2020-02-11 HU HUE20720927A patent/HUE064262T2/hu unknown
- 2020-02-11 AU AU2020222299A patent/AU2020222299C1/en active Active
- 2020-02-11 EP EP23190310.5A patent/EP4248960A3/en active Pending
- 2020-02-11 US US17/430,130 patent/US20220177439A1/en active Pending
- 2020-02-11 EA EA202192111A patent/EA202192111A1/ru unknown
- 2020-02-11 DK DK20720927.1T patent/DK3924361T3/da active
- 2020-02-11 BR BR112021015762-0A patent/BR112021015762A2/pt unknown
- 2020-02-11 PL PL20720927.1T patent/PL3924361T3/pl unknown
-
2021
- 2021-08-10 IL IL285487A patent/IL285487A/en unknown
- 2021-08-20 ZA ZA2021/06037A patent/ZA202106037B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA202192111A1 (ru) | 2022-01-26 |
| EP4248960A2 (en) | 2023-09-27 |
| IL285487A (en) | 2021-09-30 |
| BR112021015762A2 (pt) | 2021-10-05 |
| EP3924361B1 (en) | 2023-09-06 |
| AU2020222299B2 (en) | 2024-02-08 |
| EP4248960A3 (en) | 2024-01-03 |
| ZA202106037B (en) | 2022-05-25 |
| AU2020222299A1 (en) | 2021-10-07 |
| PT3924361T (pt) | 2023-12-12 |
| CN113727989B (zh) | 2024-02-13 |
| LT3924361T (lt) | 2023-12-27 |
| SI3924361T1 (sl) | 2024-02-29 |
| DK3924361T3 (da) | 2023-11-13 |
| KR20210127955A (ko) | 2021-10-25 |
| MX2021009584A (es) | 2021-09-23 |
| PL3924361T3 (pl) | 2024-03-18 |
| CN113727989A (zh) | 2021-11-30 |
| HRP20231582T1 (hr) | 2024-03-15 |
| FI3924361T3 (fi) | 2023-12-11 |
| ES2965305T3 (es) | 2024-04-12 |
| WO2020165741A1 (en) | 2020-08-20 |
| EP3924361A1 (en) | 2021-12-22 |
| CA3129743A1 (en) | 2020-08-20 |
| AU2020222299C1 (en) | 2024-05-16 |
| JP2022520384A (ja) | 2022-03-30 |
| HUE064262T2 (hu) | 2024-02-28 |
| US20220177439A1 (en) | 2022-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273842A (en) | 1-Benzyl-2-imino-4-phenyl-5-oxoimidazolidine derivatives as HIV protease inhibitors | |
| IL268282B (en) | hiv inhibitory compounds | |
| GB201916960D0 (en) | Compositions | |
| ZA202204675B (en) | New methylquinazolinone derivatives | |
| EP3285582A4 (en) | Phosphate-substituted quinolizine derivatives useful as hiv integrase inhibitors | |
| EP3377066A4 (en) | AMIDOSUBSTITUTED PYRIDOTRIAZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS | |
| EP3377065A4 (en) | SPIROCYCLIC PYRIDOTRIAZINE DERIVATIVES USEFUL AS INHIBITORS OF HIV INTEGRASE | |
| EP3548031A4 (en) | TETRACYCLIC HETEROCYCLENE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS | |
| GB201901890D0 (en) | Compositions | |
| EP4017317A4 (en) | EXTENDING TABLE | |
| IL289197A (en) | History of 2-hydroxycycloalkane-1-carbamoyl | |
| EP3277755A4 (en) | Algae-blended compositions without plasticizers | |
| EP3573984A4 (en) | USEFUL SUBSTITUTE QUINOLIZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS | |
| EP4043450A4 (en) | 2H-BENZOPYRAN DERIVATIVES USABLE AS CRAC INHIBITORS | |
| EP4017316A4 (en) | EXTENDABLE TABLE | |
| GB201908396D0 (en) | Compositions | |
| IL290964A (en) | A 2-aminoquinazolinone derivative | |
| IL290815A (en) | History of alpha-d-galactopyranoside | |
| ZA202209130B (en) | Novel triterpene derivatives as hiv inhibitors | |
| ZA202106037B (en) | Novel triterpene derivatives as hiv inhibitors | |
| EP3848365A4 (en) | TRK INHIBITORS AS AN ANTI-CANCER AGENT | |
| EP3796900A4 (en) | TRITERPENE AMINE DERIVATIVES | |
| GB201919234D0 (en) | Compositions | |
| EP3640250A4 (en) | COMPOUND USED AS A GLS1 INHIBITOR | |
| EP3924362A4 (en) | NEW TRITERPENONE DERIVATIVES AS HIV Inhibitors |